QuVa Pharma, Inc.’s Post

Click https://ow.ly/nBOH50RT3J3 to learn how innovative pharma companies add #PatientEngagement providers to the support ecosystem to offer specialized expertise, innovative technologies, and a holistic approach to patient support.

Register now: https://loom.ly/L3Auzbw Join experts from Mayne Pharma, Archbow Consulting and AssistRx on Oct. 8 at 1 p.m. ET to explore the strategies improving visibility and access at the retail channel. During the webinar, we’ll detail how the perfect blend of tech and talent can provide specialty-lite and retail patients with specialty-level access support. #InformedAccess #ImprovedOutcomes

#DYK MedImpact Healthcare Systems, Inc. has three innovative solutions that address high-cost generics (#HCG)? Built using our #clinical expertise and advanced #analytics, these tools identify and track list prices, MACs, and claim costs for more than 2,000 generic drugs – allowing us to quickly respond to price changes and maximize cost-saving opportunities. Send me a DM to learn more. #wearemedimpact #atruepartner #pharmacybenefits

Curious about the real impact of a digital adoption platform in Pharma? 🤔 Dive into this quick snapshot of all the benefits Whatfix delivers—think major productivity boosts and significant cost savings. 📈 💰 Intrigued? Know more: https://lnkd.in/eAaMPe4U #whatfix | #digitaladoption | #pharmaclickswithwhatfix

#DYK MedImpact Healthcare Systems, Inc. has three innovative solutions that address high-cost generics (#HCG)? Built using our #clinical expertise and advanced #analytics, these tools identify and track list prices, MACs, and claim costs for more than 2,000 generic drugs – allowing us to quickly respond to price changes and maximize cost-saving opportunities. Send me a DM to learn more. #wearemedimpact #atruepartner #pharmacybenefits

A wave of private equity activity in 2020–2021 has set the stage for significant M&A activity in the outsourced pharma services and pharma tech space, with 20+ notable platforms expected to come to market in 2024–2025. In addition, increased complexity of regulatory requirements and pressure on pharma companies to outsource more to specialized vendors are driving greater opportunities for investors in the sector. Our Q2 brief shares observations and key themes impacting the market, including the rising complexity and cost of the R&D process, supply chain visibility, legacy commercialization approaches, tech implementation, challenges with payers, and drivers for pharma services activity in 2024. https://lnkd.in/gYYfXn42

For complex therapies where patients may receive therapy in the office and at home, it’s difficult to assess a brand’s total transactions to inform territory alignments. Rather than relying on legacy retail data and piecemeal projections, biopharmas can optimize alignments using total prescriptions AND procedures in Veeva Compass. For one biopharma, this meant: 🔶 8,830 more HCPs 🔶 24,400 more patients 🔶 40 additional territories  🔶 $150 million in incremental opportunity   Read the story: https://bit.ly/4au0e9P #SeeMoreData #lifesciences #VeevaCompass

#DYK MedImpact Healthcare Systems, Inc. has three innovative solutions that address high-cost generics (#HCG)? Built using our #clinical expertise and advanced #analytics, these tools identify and track list prices, MACs, and claim costs for more than 2,000 generic drugs – allowing us to quickly respond to price changes and maximize cost-saving opportunities. Send me a DM to learn more. #wearemedimpact #atruepartner #pharmacybenefits

For daily News updates on the Pharma industry follow RESONACLE!!! #dailynews #pharmaceuticalindustry #pharmanews

Have you heard of Lyfegen's new Drug Contracting Simulator? It collects your inputs and enables you to craft business cases with different drug pricing models, overcoming uncertainties regarding affordability and efficacy. 🚀 Get in touch directly to learn more. #Innovation #ValueBasedHealthcare #HealthTech